Smith+Nephew Appoints Dr. Garheng Kong as Non-Executive Director to Enhance Strategic Direction and Innovation Capabilities

Smith+Nephew has appointed Dr. Garheng Kong as a Non-Executive Director, effective September 1, 2025. Dr. Kong brings experience in the medtech and biopharma sectors. The company operates in three business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management, with annual sales of $5.8 billion in 2024.

Smith & Nephew plc, a leading global medical technology company, has appointed Dr. Garheng Kong as a Non-Executive Director, effective September 1, 2025. Dr. Kong brings extensive experience in the medtech and biopharma sectors, which will contribute to the company's strategic direction and governance [1].

Dr. Kong's appointment comes at a critical time for Smith & Nephew, which operates in three key business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company reported annual sales of $5.8 billion in 2024, highlighting its significant market presence and financial performance [2].

The global wound care market, a key segment for Smith & Nephew, is projected to reach USD 30.48 billion by 2030, growing at a CAGR of 6.5% during the period. The market is driven by factors such as an aging population, increasing cases of traumatic injuries, and the rising prevalence of chronic diseases. However, high costs of advanced wound care products may restrain growth [3].

Smith & Nephew's appointment of Dr. Kong underscores its commitment to fostering a diverse and experienced board to navigate the challenges and opportunities in the medtech sector. His expertise will be crucial in driving the company's strategic initiatives and ensuring robust governance practices.

References
[1] https://www.tradingview.com/news/reuters.com,2025-08-22:newsml_RSV5020Wa:0-reg-smith-nephew-plc-director-pdmr-shareholding/
[2] https://www.globenewswire.com/news-release/2025/08/27/3139834/28124/en/Wound-Care-Industry-Research-Report-2025-2030-Featuring-Strategic-Analysis-of-Solventum-Johnson-Johnson-Services-Ethicon-Smith-Nephew-Cardinal-Health-and-Molnlycke-Among-Others.html